(6RS)-5- 6, 7, LV) was treated with an alkyl or aralkyl halide in dimethyl sulfoxide in the presence of cesium carbonate or sodium carbonate to obtain the heretofore undescribed di-n-hexyl, dibenzyl, di(3,4-dimethylbenzyl), di(2,4,6-trimethylbenzyl), di(2,6-dichlorobenzyl), and di(4-methoxybenzyl) esters in yields of up to 70% . Also prepared were the dibenzyl ester (6RS)-5-methyl-5,6,7,8-tetrahydrohomofolic acid (MeTHHF) and the di(2,6-dichlorobenzyl) ester of folic acid. Formation of the 2,6-dichlorobenzyl esters was more rapid than that of the other esters, reflecting the high reactivity of 2,6-dichlorobenzyl bromide, and proceeded satisfactorily even in the presence of sodium carbonate. Esterification of folic acid and MeTHHF with benzyl chloride was complicated by side reactions involving alkylation of the pteridine moiety, but when folic acid was treated with 2,6-dichlorobenzyl bromide instead of benzyl chloride these side reactions were not a problem. As expected, the diesters of LV and MeTHHF were very lipophilic, and dissolved readily in organic solvents but not water.
Introduction
Diesters of the classical antifolate methotrexate (MTX) and its close analogues dichloromethotrexate and aminopterin have been prepared by various methods from the parent acids (1 -3) , and display novel biochemical and pharmacological properties related to their lipophilic character (4) (5) (6) (7) (8) . Diesters of the reduced folate derivative (6RS)-5-formyl-5,6,7,8-tetrahydrofolic acid (1, leucovorin, LV) are also of interest, both as laboratory tools and as potential therapeutic agents. LV has been used clinically for many years to treat poisoning due to accidental overdoses of folate antagonists. In the treatment of certain forms of cancer, the ability of LV to counteract I) Paper 39 in this series: for previous paper, sec : antifolate toxIcity has also been advantageous as a " rescue" modality in high-dose MTX regimens (reviewed in ref. 9 ). More recently, great interest has developed in LV as a modulating agent for fluorouracil (FU) (reviewed in ref. 10 ). The rationale for this therapeutic strategy is that LV expands the pool of 5,10-methylenetetrahydrofolate polyglutamates in tumors, which in turn enhances the ability of 5-fluoro-2' -deoxyuridine 5' -phosphate (FdUMP) to block thymidylate synthase activity and cause "thymineless death" (reviewed in ref. 11 ).
As a reduced folate derivative, LV is tra nsported into cells via an energy-requiring and saturable carriermediated process. Moreover, its accumulation, as well as that of its subsequent biologically active metabolites such as 5,10-methylenetetrahydrofolate, is promoted by conversion to non-effluxing polyglutamates (12, 13) . However, because the polyglutamylation of LV is less efficient than that of other reduced folates (14) , its uptake may be limiting where expansion of the 5,1 O-methylenetetrahydrofolate pool and eventual potentIation of FU are concerned. Tumors lacking the ability to efficiently transport reduced folates may be expected to be less responsive to LV + FU than tumors with a normal capacity for reduced folate transport. This situation that could arise, for example, in a patient whose tumor after therapy with MTX has become refractory as a result of a transport mutation . Recent evidence suggests that impaired LV uptake may even arise collaterally with resistance to agents other than antifolates. Specifically, Osieka and coworkers (15) have reported that L1210 murine leukemic cells selected for expression of the multidrug resistance (MDR) phenotype (see ref. 16 for an overview of MDR) by cultivation in the presence of etoposide lose the ability to be protected by LV from the toxic effects of MTX. While there may be other explanations for this novel finding , it is possible that LV transport, and hence accumulation of reduced folate polyglutamates, becomes inefficient not only in MTX-resistant cells but also in cells with the MDR phenotype. Such cells may be expected to be resistant to LV + FU unless means are found to by-pass the LV transport defect. One approach to increasing the amount of LV that can enter cells is to render it lipophilic by esterification of the glutamate carboxyl groups. This paper, which is. to our knowledge, the first detailed report on the chemical synthesis of LV diesters, describes the preparation of a representative number of these compounds in good yield by alkylation of the disodium or dicesium salt of LV with an alkyl or aralkyl halide in DMSO.
Treatment of the free acid of LV with two molar equivalents of l-iodohexane and four molar equivalents of sodium carbonate in DMSO at room temperature afforded a relatively non-polar product which, unlike LV itself, could be passed readily through a silica gel column using various chloroformmethanol mixtures. Diester 2 was obtained in 54% yield, a value comparable to that found earlier in the reaction of l-iodohexane with MTX in the presence of cesium rather than sodium carbonate (3). In the hope that the carboxylate groups would be more efficiently alkylated if the counter-ion were cesium instead of sodium, the free acid of LV was converted to a dicesium salt by dissolving it in water, adjusting the pH to 7.5 with 20% cesium carbonate, freezedrying thc solution, and removing final traces of moisture by azeotropic distillation with benzene. Suspensions of the thoroughly dried dicesium salt in dry DMSO were then treated with 4 molar equivalents (twofold excess) of benzyl or 3,4-dimethylbenzyl chloride for 42 h to obtain the diesters 3 and 4, respectively. In a variant of this method, a mixed suspension of LV free acid and cesium carbonate in DMSO was treated with 2,4,6-trimethylbenzyl chloride for 22 h or 4-methoxybenzyl chloride for 22 h to obtain the diesters 5 and 6, respectively. Non-optimized yield were mostly 60-70%, and it appeared to make little difference whether the reaction was performed with the dicesium salt of LV or with the diacid in the presence of sodium or cesium carbonate.
Nmr spectra were obtained for two of the diesters (2 and 3) in d 6 -DMSO solution. Although it was not possible to resolve the peaks corresponding to the OCH 2 protons of the r:t-and ,),-ester groups in 2, discrete singlets at 84.97 and 8 5.02 were readily discernible in the spectrum of the dibenzyl ester 3. The upfield signal was assigned to the r:t-ester, whereas the downfield signal was assigned to the ,),-ester. Interestingly, the resonance signal corresponding to the N 5 -formyl group was split into two peaks of roughly equal area, totaling one proton, at 88.2 and 88.3 (NCH = 0). These results are consistent with hindered rotation of the amide bond.
Since it had been previously observed that 2,6-dichlorobenzyl bromide reacts faster than other benzylic halides with the carboxyl groups in MTX (3), it was of interest to extend this observation to LV and folic acid. Treatment of LV in DMSO with two molar equivalents of2,6-dichlorobenzyl bromide (i. e., a stoichiometric amount rather than an excess) afforded a 67% yield of diester 7 after only 4 h. The high reactivity of 2,6-dichlorobenzyl bromide is believed to be due to the electron-withdrawing character of the two ortho-chloro substitutents and to the steric relief afforded by replacement of the bromine with a smaller oxygen atom when an ester is formed.
Esterification of the experimental antitumor agent (6RS)-5-methyl-5,6,7,8-tetrahydrohomofolic acid (8) (reviewed in ref. 17 ) was also examined, with the aim of assessing the effect of N 5 -methyl versus N S-formyl substitution. Reaction of 8 with a stoichiometric amount of benzyl chloride and a twofold molar excess of cesium carbonate in DMSO was found to be slow, and was clearly not complete after the normal 24--48 h. After 88 h, however, a crude product was obtained whose TLC showed mainly one spot with Rr 0.86. Purification by column chromatography and preparative TLC afforded a low yield (10%) of a compound whose microanalysis indicated the empirical formula C42H4SN 70 6 . 0.25H 2 0 and was therefore consistent with the incorporation of three benzyl groups. The nmr spectrum of this compound, in CDC!; solution, showed it to be a diester since the CH 2 protons of the (J..-and y-benzyl ester groups were visible at 8 5.0 and 8 5.1, respectively. In addition there were two aromatic singlets, one at 87.30 (ten protons) which we assigned to the ester O-benzyls, and the other at 8 7.17 (five protons) which we viewed as being consistent with an N-benzyl group. This compound was therefore provisionally formulated as the N 3 -benzyl derivative. It appears from these results that the NS-formyl group in 1 may indirectly decrease the nucleophilic reactivity of N 3 , thereby diminishing susceptibility to attack by alkyl or aralkyl halides. In an effort to minimize N 3 -benzylation, 8 was allowed to react with henzyl chloride and half the normal amount of cesium carbonate. After 4 days, TLC revealed mainly two spots with Rr 0.72 and Rr 0.86. The slower-moving spot, which we assumed might be the diester 10 because its R r was similar to those of the LV diesters, was isolated , albeit in relatively low yield (19%), by preparative chromatography. Its stucture was confirmed as 10 by elemental analysis, which indicated the empirical formula C3sH 3XN 70 6 . 2H 2 0, and on the basis of the nmr spectrum , which was similar to that of 9 except for the absence of a signal at 87.17.
Further support for the idea that the N 5 -formyl group in LV may indirectly enhance the selectivity of alkylation of the glutamate carboxyls by diminishing alkylation of the pteridine moiety was derived from the 145 reaction of benzyl chloride with the cesium salt of folic acid in DMSO. TLC analysis of the crude product obtained after 41 h at room temperature revealed mainly two relatively fast-moving spots with Rr 0.84 (Product A) and Rr 0.87 (Product B). The two products were separated by column chromatography and analyzed. Product A (35% yield, mp 105 -114 "C) was found to have the empirical formula C4oH 37N 70 6 . 2H 2 0, and product B (15% yield, mp 197 -202 "c) was found to have the empirical formula C 4o H )7N 7 0 6 . 0.5H 2 0. Thus both products were tribenzyl derivatives, and no dibenzyl folate was obtained. It is of interest in this regard that Temple and coworkers (18) have reported that alkylation of folic acid with methyl iodide in N,N-dimethylacetamide in the presence of potassium carbonate fails to stop at the dimethyl ester stage, but gives instead N' ,N 3 -dimethylfolate. It was also found that reaction of dimethyl folate with methyl iodide in the presence of base yields dimethyl N 3 -methylfolate. On the basis of this precedent which suggests that N 3 is favored over N' (as well as N'O) for alkylation, we believe that product B from the reaction of benzyl chloride with folic acid was probably dibenzyl N 3 -benzylfolate. Product A may have been the N'-benzyl diester, though other sites of alkylation, such as the 2-amino group, N lo , or 0 6 , were not ruled out. Because our primary interest was in the esterification of LV and not folic acid, further work on these compounds was not pursued. Intcrestingly, when the esterification of folic acid was performed with 2,6-dichlorobenzyl bromide the 2,6-dichlorobenzyl ester 11 was obtained. The yield of 11 was comparable to that of the LV esters, and concomitant alkylation of the pteridine moiety, unlike the reaction of folic acid with benzyl chloride, did not appear to be a problem.
In summary, this report describes a mild and general method of neutral esterification of LV using alkyl or aralkyl halides in the polar solvent DMSO. An easy opportunity is thereby afforded to obtain lipophilic diester derivatives for evaluation of their biochemical and pharmacologic properties in comparison with the parent acid. Preparation of leucovorin freee acid (1) from the calcium salt Calcium leucovorin (1 g) was dissolved in H 2 0 (20 mL) with slight warming, and the solution was treated dropwise with formic acid (0.5 mL) until the pH reached 3.5, cooled to 3 D C in an ice bath, and filtered. The filter cake was dried in vacuo over P 2 0 S to obtain a beige solid (681 mg). On overnight storage in the refrigerator, the mother liquor yielded 1 as a paleyellow solid (56 mg) which was chromatographically identical to the first crop; total yield 737 mg (67%); mp 249 -252 cC; TLC: Rr 0.66 (Eastman 13254 cellulose, 1 : 1 EtOH, pH 7.4 phosphate buffer). This material was used without further purification to prepare the diesters. (2) 1-lodohexane (85 mg, 0.4 mmol) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and Na2CO] (42 mg, 0.4 mmol) in DMSO (4 mL), and the mixture was stirred at room temperature for 24 h. After evaporation of the DMSO, the residue was triturated with H 2 0 (25 mL), filtered, and dried in vacuo over P 2 0 S to obtain a cream-colored solid (105 mg). The solid was dissolved in a minimum of 98: 2 CHClrMeOH and applied onto a silica gel column (5 g) which was eluted successively with CHClrMeOH mixtures (98: 2, 25 x 8 mL; 96 : 4, 25 x 8 mL; 94: 6, 25 x 8 mL; 92 : 8, 25 x 8 mL). The column eluates were monitored by TLC (silica gel, 3: 1 CHCb-MeOH) and tubes 39 -72 were pooled and evaporated to obtain a pale-yellow solid (69 mg, 54 % yield); mp 124 -130 D C. A sample (30 mg) of 2 was re-purified for analysis by chromatography on 
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Leucovorin di-n-hexyl ester
Leucovorin dibenzyl ester (3)
Leucovorin free acid (200 mg, 0.38 mmol) was suspended in H 2 0 (4 mL), the pH of this mixture was adjusted to 7.5 with 20% CS 2 C0 3 (1 mL), and the solution was evaporated to dryness. The residue was dried azeotropically with benzene (2 x 20 mL) and then suspended in DMSO (6 mL) and treated with a solution of benzyl chloride (192 mg, 1.52 mmol) in DMSO (1.5 mL) . After being stirred at room temperature for 42 h, the mixture was evaporated to dryness, and the residue was triturated with H 2 0 (5 mL) and filtered. The crude diester was washed with H 2 0 and dried overnight in a vacuum desiccator over P 2 0 S to obtain a beige solid (271 mg). A portion (150 mg) of this material was chromatographed on a column of silica gel (8 g) which was eluted successively with CHClrMeOH mixtures (100 mL each) ranging in composition from 99: 1 to 91 : 9. The MeOH content of the eluents was increased in 1 % increments, and individual fractions (9 mL) were monitored by TLC. Tubes 51 -100 were combined and evaporated, and the residue was triturated with ether and dried in vacuo over P 2 0 S to obtain a beige solid (95 mg); the rest of the crude diester (120 mg) was purified similarly. The total yield of 3 was 173 mg (70%); mp 133 -138°C. TLC: Rr 0.69; JR: v 1750 (ester C = 0); UV: Amax 293 nm (E 35,580). Two repetitions of this synthesis, one starting from 0.5 g of leucovorin free acid and the other from 0.9 g, gave yields of 57 and 78%, respectively. 
Leucovorin di-( 3,4-dimethylbenzyl) ester (4)
Leucovorin (100 mg, 0.19 mmol) was converted to its dicesium salt and the latter allowed to react with 3,4-dimethylbenzyl chloride (118 mg, 0.76 mmol) in DMSO as described for the dibenzyl ester. The crude product (160 mg) was chromatographed on a column of silica gel (7 g ) by elution with CHClrMeOH mixtures (98 : 2, 44 x 9 mL; 96 : 4, 44 x 9 m L; 94 : 6, 44 x 9 mL). Tubes 61-110 were pooled and evaporated to a pale-yellow solid (40 mg, 30 % yield). Analytically pure 4 was obtained after a second passage through silica gel; mp 136 -143 "C; TLC : Rr 0.81.
Anal.
Calcd. C 3sH43N707 . 0.5CH 3 0H C 63 .71 H 6.25 N 13.51 Found C 63.86 H 6.62 N 13.66
Leucovorin di- (2, 4,6-trimethylbenzyl ) ester (5) 2,4,6-Trimethylbenzyl chloride (138 mg, 0.8 mmol) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and Cs 2 CO J (130 mg, 0.4 mmol) in DMSO (5 mL), and the mixture was stirred at room temperature for 22 h and worked up as in the preparation of the di-n-hexyl ester. The crude diester was chromatographed on a column of silica gel (6 g) which was eluted with CHClrMeOH mixtures (98 : 2. 43 x 7 mL; 96: 4, 43 x 7 mL). Tubes 56 -82 were combined and evaporated under reduced pressure to obtain 5 as a pale-yellow solid (88 mg, 60% yield); mp 147 - 
Leucovorin di-( 4-methoxybenzyl) ester (6)
A solution of 4-methoxybenzyl chloride (125 mg, 0.8 mmo!) in DMSO (1 mL) was added to a suspension of leucovorin free acid (105 mg, 0.2 mmol) and CS 2 C0 3 (130 mg, 0.4 mmol) in DMSO (4 mL). After 42 h at room temperature, the DMSO was evaporated under reduced pressure and the resid ue triturated with H 2 0 (30 mL) . The resulting gum was extracted with CHCh (5 x 20 mL) and the combined CHCl J extracts were washed with H 2 0 (30 mL), dried over Na2S04, and evaporated. The brown-colored semi-solid residue was chromatographed on a column of silica gel (5 g) which was eluted with CHClrMeOH mixtures (98: 2, 37 x 8 mL; 96: 4, 25 x 8 mL; 94: 6, 25 x 8 mL). Tubes 76 -102 were pooled and evaporated to obtain 6 as a beige solid (99 mg, 70% yield); mp 118 -125 cC; TLC: R r O.75; IR : v 1740 (ester C = 0); UV: Amax 293 nm (£ 34,615); NMR : 01.8 -2.3 (broad m , 4H, CH 2 CH 2 COOR and C 7-or 9-CH z ), 2.8 -3.3 (broad , 5H, CH 2 CH 2 COOR, 6-H, and 7-or 9-CH 2 ), 3. Esterification of ( 6RS) -5-methyl-5,6,7,8-tetrahydrohom() 
j"olic acid (8) with benzyl chloride
Procedure A A solution of benzyl chloride (50.6 mg, 0.4 mmol) in DMSO (1 mL) was added dropwise to a stirred suspension of 8 (94.7 mg, 0.2 mmol) and CS 2 C0 3 (130 mg, 0.4 mmol) in DMSO (3 mL). After being stirred at room temperature for 88 h, the reaction mixture was evaporated under reduced pressure, and the residue was triturated with pH 7.4 phosphate buffer, washed with H 2 0 , and dried in vacuo over P 2 0 S to obtain a beige solid (104 mg). The product was applied onto a silica gel column which was eluted with CHClrMeOH mixtures (99: 1, 22 x 9 mL; 98: 2, 22 x 9 mL). 
Esterification of folic acid with benzyl chloride
Folic acid (100 mg, 0.23 mmol) was dissolved in H 2 0 (2 mL) by addition of 20% CS 2 C0 3 (0.5 mL) to bring the pH to 7.5. The solution was evaporated to dryness under reduced pressure and the residue was dried azeotropically with benzene (2 x 15 mL) and then in vacuo over P20S' The dried cesium salt was suspended in DMSO (4 mL) and a solution of benzyl chloride (86 mg, 0.68 mmol) in DMSO (1 mL) was added. After 41 h at room temperature, the DMSO was evaporated under reduced pressure, and the residue was triturated with H 2 0 (25 mL), filtered, washed with H 2 0, and dried in vacuo over P 2 0 S to obtain a yellow-
Rosowsky and Yu : Leucovorin esters orange solid (53 mg) whose TLC showed two main spots with Rr 0.84 (product A) and Rr 0.87 (product B). The darkest spot was that of product B. The crude product mixture was dissolved in a minimum volume of 98: 2 CHClr MeOH and applied onto a silica gel column (7 g ) which was eluted with CHClrMcOH mixtures (98 : 2, 22 x 9 mL; 96: 4, 22 x 9 mL; 94: 6, 22 x 9 mL). Individual tubes were monitored by TLC, and appropriate tubes were combined and evaporated. While it appeared from the microchemical analyses that compounds A and B were isomeric tribenzyl derivatives, the position of benzylation on the pterin moiety was left unassigned.
Folic acid di-( 2,6-dichlorobenzyl) ester (ll)
A solution of 2,6-dichlorobenzyl bromide (220 mg, 0.92 mmol) in DMSO (3 mL) was added at a rate of 1 mLjh to a stirred suspension of folic acid (200 mg, 0.46 mmol) and Na2CO) (0.92 mmol) in DMSO (5 mL), and after 2 days at room temperature the reaction mixture was evaporated to dryness under reduced pressure. The residue was triturated with H 2 0 (30 mL), and dried in vacuo over P 2 0 S . This material (340 mg) was then triturated with 3: 1 CHCh-MeOH and the insoluble residue collected as a yellow solid by centrifugation (135 mg). The supernatant was evaporated and the residue chromatographed on a silica gel column (20 g) by elution with CHClrMeOH mixtures (95:5,33 x 9 mL; 9 : 1, 22 x 9 mL; 4 : 1, 22 x 9 mL; 7:3, 110 x 9 mL). Tubes 64 -144 were pooled and evaporated to obtain a yellow solid (34 mg). This material was indistinguishable from the main product; total yield 174 mg (51 %); dec 265°C, 
